Starting Statins Early After Diabetes Diagnosis Linked to Lower Dementia Risk
Researchers found statin use after a type 2 diabetes diagnosis was linked to a 10% lower dementia risk, rising to 15% when started early.
- On Sunday, researchers presented a study at the ESC Congress 2026 showing that early statin use after a type 2 diabetes diagnosis is associated with reduced dementia risk compared to non-users.
- Researchers tracked 132,585 statin-naïve individuals in Denmark between 2006 and 2021, utilizing a median follow-up of 7.1 years to compare early and late treatment outcomes.
- Data indicated a 15% lower relative risk for early initiation over 10 years, while late initiation showed a 10% reduction, with results consistent in both women and men.
- Doctor Tummas Ternhamar of Copenhagen University Hospital explained, "Detecting and treating high levels of low-density lipoprotein cholesterol from midlife is one such highlighted risk factor."
- While the research cannot prove prevention, Ternhamar suggested these findings strengthen the case for offering statins alongside lifestyle measures, though further research should inform future clinician discussions.
14 Articles
14 Articles
Starting statins early after diabetes diagnosis linked to lower dementia risk
Early initiation of statins after diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study presented today at ESC Congress 2026 and published in The Lancet Regional Health – Europe.
(Seoul = Yonhap News) Reporter Lee Joo-young = People diagnosed with type 2 diabetes who started statin treatment, a cholesterol-lowering drug, within one year... five years after diagnosis ...
A recent scientific study has shown that the early initiation of cholesterol reduction drugs is associated with the low risk of dementia in infected persons.
Coverage Details
Bias Distribution
- 43% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
















